ReviewCureus2026
Allergy Diagnosis in India: Current and Future Trends.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Allergies, particularly allergic rhinitis (AR), atopic dermatitis (AD), and food allergies, are highly prevalent in India, especially among children. However, the true prevalence is likely underestimated, highlighting the need for improved diagnosis and management. This review highlights current allergy diagnostic practices in India and the associated challenges. Accurate diagnosis requires a comprehensive, allergy-focused patient history, correlated with appropriate in vivo and/or in vitro diagnostic test results. This necessitates awareness among healthcare professionals about allergies as a disease and the timely referral of patients to allergy specialists. However, ambiguities in diagnostic techniques, limited access to advanced diagnostic tools, high associated costs, fragmented allergy services, and evolving allergen profiles influenced by environmental and lifestyle changes present significant barriers to diagnosis. Addressing gaps in accessibility, affordability, and awareness is essential for establishing a robust framework for accurate diagnosis, ultimately improving patient outcomes and quality of life. The burden of allergic diseases in India remains underdiagnosed due to limited diagnostic capacity. Diagnosis is typically based on clinical history and tests, such as the skin prick test (SPT) and specific immunoglobulin E (IgE) measurement. However, challenges such as low awareness, unclear techniques, and limited access to standardized tools persist. Combining component-resolved diagnosis (CRD) with traditional tests can enhance accuracy and guide better treatment decisions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.